In this study, the therapeutic effect of MSCs after TGFβ1 transduction was significantly improved, due mainly to the better regulation of T cell differentiation in ARDS mice on day 3 and day 7 and reduced Th17/Treg ratio, thus balancing inflammatory cytokines in vivo. This evidence concerns the gene TGFB1 and acute respiratory distress syndrome.